Abstract P5-17-01: Development and validation of the Penn arthralgia aging scale among breast cancer survivors on aromatase inhibitors
Conclusions: These findings suggest that the PAAS is a reliable and valid tool that captures a meaningful construct of perceptions of aging attributable to arthralgia. With further research, the PAAS may advance our understanding of breast cancer survivors’ emotional, behavioral, and clinical outcomes.
Citation Format: Moriah J Brier, Dianne L Chambless, Laura Lee, Angela DeMichele, Jun J Mao. Development and validation of the Penn arthralgia aging scale among breast cancer survivors on aromatase inhibitors [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2014 Dec 9-13; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2015;75(9 Suppl):Abstract nr P5-17-01.
Source: Cancer Research - Category: Cancer & Oncology Authors: Brier, M. J., Chambless, D. L., Lee, L., DeMichele, A., Mao, J. J. Tags: Poster Session Abstracts Source Type: research
More News: Anxiety | Breast Cancer | Cancer | Cancer & Oncology | Depression | Genetics | Health | Hormones | Men | Menopause | Nurses | Nursing | Pain | Study | Women